Anti-Integrin a4b7 (ITGA4 & ITGB7) Antibody (Etrolizumab)
Catalog No.
F1884
Anti-Integrin a4b7 (ITGA4 & ITGB7) Antibody (Etrolizumab)
Featured Products
Etrolizumab (rhuMAb Beta7) is a gut-selective anti-β7 integrin monoclonal antibody. Etrolizuma b is a specific active molecule targeting the β7 subunit of α4β7 and αEβ7 integrins. Etrolizumab can be used in the research of inflammatory bowel disease (IBD).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.3 kDa
Dry ice
1044758-60-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
rhuMAb Beta7, Anti-beta7, PRO145223
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P13612 & P26010
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Integrin a4b7 (ITGA4 & ITGB7)
Please avoid freeze-thaw cycles.